Option Care Health, Inc. (OPCH) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Care Facilities Branche. Der Hauptsitz des Unternehmens ist in Bannockburn, IL, United States. Der aktuelle CEO ist John C. Rademacher.
OPCH hat IPO-Datum 1996-08-15, 8,000 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $4.36B.
Option Care Health, Inc. is a leading provider of home and alternate site infusion services throughout the United States, headquartered in Bannockburn, Illinois. The company delivers a comprehensive range of specialized therapies including anti-infective treatments, home infusion services for heart failure, parenteral and enteral nutrition support, immunoglobulin therapies, and treatments for chronic inflammatory disorders such as Crohn's disease, rheumatoid arthritis, and ulcerative colitis. Additionally, Option Care Health provides therapies for neurological disorders, bleeding disorders, high-risk pregnancy management, and other infusion-based treatments including pain management, chemotherapy, and respiratory medications, supported by integrated nursing services.
